Role of human matrix metalloproteinases in malaria pathogenesis

Malaria: Etiology, Pathogenesis and Treatments

Volumn , Issue , 2012, Pages 151-174

  Prato, Mauro ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Italian Malaria Network   (Italy)

Author keywords

Cerebral malaria (CM); Haemozoin (HZ); Malaria; Matrix metalloproteinases (MMPs); Plasmodium falciparum; Tissue inhibitors of metalloproteinases (TIMPs)

Indexed keywords

EID: 82455182950     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (113)

1. Abrams ET, Brown H, Chensue SW, Turner GD, Tadesse E, Lema VM, Molyneux ME, Rochford R, Meshnick SR, Rogerson SJ. Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated beta chemokine expression. J Immunol. 2003; 170:2759-64.
2. Andolfo A, English WR, Resnati M, Murphy G, Blasi F, Sidenius N. Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor. Thromb Haemost. 2002; 88:298-306.
3. Armah HB, Wilson NO, Sarfo BY, Powell MD, Bond VC, Anderson W, Adjei AA, Gyasi RK, Tettey Y, Wiredu EK, Tongren JE, Udhayakumar V, Stiles JK. Cerebrospinal fluid and serum biomarkers of cerebral malaria mortality in Ghanaian children. Malar. J. 2007;6:147.
4. Asahi M, Wang X, Mori T, Sumii T, Jung JC, Moskowitz MA, Fini ME, Lo EH. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 2001;21:7724-32.
5. Beeson JG, Duffy PE. The immunology and pathogenesis of malaria during pregnancy. Curr. Top Microbiol. Immunol. 2005;297:187-227.
6. Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim. Biophys. Acta. 2010;1803:55-71.
7. Bruni-Cardoso A, Augusto TM, Pravatta H, Damas-Souza DM, Carvalho HF. Stromal remodelling is required for progressive involution of the rat ventral prostate after castration: identification of a matrix metalloproteinase-dependent apoptotic wave. Int. J. Androl. 2010;33:686-95.
8. Buffet PA, Safeukui I, Milon G, Mercereau-Puijalon O, David PH. Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr. Opin. Hematol. 2009;16:157-64,
9. Buommino E, Baroni A, Canozo N, Petrazzuolo M, Nicoletti R, Vozza A, Tufano MA. Artemisinin reduces human melanoma cell migration by down-regulating alpha V beta 3 integrin and reducing metalloproteinase 2 production. Invest New Drugs. 2009;27:412-8.
10. Carney CK, Schrimpe AC, Halfpenny K, Harry RS, Miller CM, Broncel M, Sewell SL, Schaff JE, Deol R, Carter MD, Wright DW. The basis of the immunomodulatory activity of malaria pigment (hemozoin). J. Biol. Inorg. Chem. 2006;11:917-29.
11. Cauwe B, Van den Steen PE, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit. Rev. Biochem. Mol. Biol. 2007 May-Jun;42(3):113-85.
12. Chulay JD, Ockenhouse CF. Host receptors for malaria-infected erythrocytes. Am. J. Trop. Med. Hyg. 1990;43:6-14.
13. Clark IA, Alleva LM, Budd AC, Cowden WB. Understanding the role of inflammatory cytokines in malaria and related diseases. Travel Med. Infect. Dis. 2008;6:67-81.
14. Clark IA, Budd AC, Alleva LM, Cowden WB. Human malarial disease: a consequence of inflammatory cytokine release. Malar. J. 2006;5:85.
15. Costa FT, Avril M, Nogueira PA, Gysin J. Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway. Braz. J. Med. Biol. Res. 2006;39:1525-36.
16. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science. 2002;295:2387-92.
17. Covington MD, Burghardt RC, Parrish AR. Ischemia-induced cleavage of cadherins in NRK cells requires MT1-MMP (MMP-14). Am. J. Physiol. Renal Physiol. 2006;290:F43-51.
18. de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology. 2010;137:755-72.
19. Deininger MH, Fimmen B, Kremsner PG, Meyermann R, Schluesener HJ. Accumulation of endostatin/collagenXVIII in brains of patients who died with cerebral malaria. J. Neuroimmunol. 2002;131:216-21.
20. Deininger MH, Winkler S, Kremsner PG, Meyermann R, Schluesener HJ. Angiogenic proteins in brains of patients who died with cerebral malaria. J. Neuroimmunol. 2003;142:101-11.
21. Dell'agli M, Galli GV, Bulgari M, Basilico N, Romeo S, Bhattacharya D, Taramelli D, Bosisio E. Ellagitannins of the fruit rind of pomegranate (Punica granatum) antagonize in vitro the host inflammatory response mechanisms involved in the onset of malaria. Malar. J. 2010;9:208.
22. Devel L, Czarny B, Beau F, Georgiadis D, Stura E, Dive V. Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity. Biochimie. 2010;92:1501-8.
23. Di Mari JF, Saada JI, Mifflin RC, Valentich JD, Powell DW. HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts. Am. J. Physiol. Gastrointest Liver Physiol. 2007;293:G719-28.
24. Dietmann A, Helbok R, Lackner P, Issifou S, Lell B, Matsiegui PB, Reindl M, Schmutzhard E, Kremsner PG. Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity. J. Infect. Dis. 2008;197:1614-20.
25. Egan TJ. Recent advances in understanding the mechanism of hemozoin (malaria pigment) formation. J. Inorg. Biochem. 2008;102:1288-99.
26. Ehrich JH, Eke FU. Malaria-induced renal damage: facts and myths. Pediatr. Nephrol. 2007;22:626-37.
27. Eisenhut M. Changes in ion transport in inflammatory disease. J. Inflamm. (Lond). 2006;3:5.
28. Fauser S, Deininger MH, Kremsner PG, Magdolen V, Luther T, Meyermann R, Schluesener HJ. Lesion associated expression of urokinase-type plasminogen activator receptor (uPAR, CD87) in human cerebral malaria. J. Neuroimmunol. 2000;111:234-40.
29. Fiore E, Fusco C, Romero P, Stamenkovic I. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene. 2002;21:5213-23.
30. Fried M, Muga RO, Misore AO, Duffy PE. Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associated with pregnancy outcomes. J. Immunol. 1998;160:2523-30.
31. Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements JM, Crimmin M, Davidson AH, Drummond AH, Galloway WA, Gilbert R, et al. Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukoc. Biol. 1995;57:774-7.
32. Geurts N, Martens E, Van Aelst I, Proost P, Opdenakker G, Van den Steen PE. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3. Biochemistry. 2008;47:2689-99.
33. Giebel SJ, Menicucci G, McGuire PG, Das A. Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab. Invest. 2005;85:597-607.
34. Giribaldi G, Prato M, Ulliers D, Gallo V, Schwarzer E, Akide-Ndunge OB, Valente E, Saviozzi S, Calogero RA, Arese P. Involvement of inflammatory chemokines in survival of human monocytes fed with malarial pigment. Infect. Immun. 2010;78:4912-21.
35. Giribaldi, Valente E, Khadjavi A, Polimeni M, Prato M. Macrophage Inflammatory Protein1alpha mediates Matrix Metalloproteinase-9 enhancement in human adherent monocytes fed with malarial pigment. Asian Pac. J. Trop. Med. 2011a; in press.
36. Giribaldi G, Ulliers D, Valente E, Khadjavi A, Mandili G, Polimeni M, Prato M. Malarial pigment promotes expression and release of TIMP-1 in human monocytes: role of MIP1alpha chemokine and NF-kappaB pathway. Proceedings of the 1st French-Italian Joint Meeting on Subcellular Trafficking, Padua, Italy, 25-28 May 2011. 2011b; P28:96.
37. Gomis-Rüth FX, Maskos K, Betz M, Bergner A, Huber R, Suzuki K, Yoshida N, Nagase H, Brew K, Bourenkov GP, Bartunik H, Bode W. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature. 1997;389:77-81.
38. Gorodeski GI. Estrogen decrease in tight junctional resistance involves matrixmetalloproteinase-7-mediated remodeling of occludin. Endocrinology. 2007;148:218-31.
39. Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, Marsh K, Relman DA, Kwiatkowski DP. Genomewide analysis of the host response to malaria in Kenyan children. J. Infect. Dis. 2005;191:1599-611.
40. Green JA, Thi Hong Chau T, Farrar JJ, Friedland JS, Thwaites GE. CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features. Neurology. 2011;76:577-579.
41. Gross J, Lapière CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc. Natl. Acad. Sci. U S A. 1962;48:1014-22.
42. Gurney KJ, Estrada EY, Rosenberg GA. Blood-brain barrier disruption by stromelysin-1 facilitates neutrophil infiltration in neuroinflammation. Neurobiol. Dis. 2006;23:87-96.
43. Hwang YP, Yun HJ, Kim HG, Han EH, Lee GW, Jeong HG. Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKCalpha/Raf/MAPKs and NF-kappaB/AP-1-dependent mechanisms. Biochem. Pharmacol. 2010;79:1714-26.
44. Ichikawa Y, Ishikawa T, Momiyama N, Kamiyama M, Sakurada H, Matsuyama R, Hasegawa S, Chishima T, Hamaguchi Y, Fujii S, Saito S, Kubota K, Hasegawa S, Ike H, Oki S, Shimada H. Matrilysin (MMP-7) degrades VE-cadherin and accelerates accumulation of beta-catenin in the nucleus of human umbilical vein endothelial cells. Oncol. Rep. 2006;15:311-5.
45. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell Mol. Biol. 2004;30:761-70.
46. Idro R, Marsh K, John CC, Newton CR. Cerebral malaria: mechanisms of brain injury and strategies for improved neurocognitive outcome. Pediatr. Res. 2010;68:267-74.
47. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J. Biol. Chem. 1999;274:34260-6.
48. Jung K, Measurement of matrix metalloproteinases and their tissue inhibitors in serum produces doubtful results. J. Infect. Dis. 2008;198:1722-3.
49. Khadjavi A, Giribaldi G, Prato M. From control to eradication of malaria: the end of being stuck in second gear? Asian Pac. J. Trop. Med. 2010;3:412-420.
50. Kojima S, Itoh Y, Matsumoto S, Masuho Y, Seiki M. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett. 2000;480:142-6.
51. Lesiak A, Narbutt J, Sysa-Jedrzejowska A, Lukamowicz J, McCauliffe DP, Wózniacka A. Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus. Lupus. 2010;19:683-8.
52. Lijnen HR. Elements of the fibrinolytic system. Ann. N Y Acad. Sci. 2001;936:226-36.
53. Lijnen HR. Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry (Mosc). 2002;67:92-8.
54. Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 2006;113:2919-28.
55. Lohi J, Wilson CL, Roby JD, Parks WC. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J. Biol. Chem. 2001;276:10134-44.
56. Lucchi NW, Sarr D, Owino SO, Mwalimu SM, Peterson DS, Moore JM. Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells. Placenta. 2011;32:579-85.
57. Medana IM, Turner GD. Human cerebral malaria and the blood-brain barrier. Int. J. Parasitol. 2006;36:5.
58. Miller CM, Carney CK, Schrimpe AC, Wright DW. beta-Hematin (hemozoin) mediated decompostion of polyunsaturated fatty acids to 4-hydroxy-2-nonenal. Inorg. Chem. 2005;44:2134-6.
59. Mohan A, Sharma SK, Bollineni S. Acute lung injury and acute respiratory distress syndrome in malaria. J. Vector Borne Dis. 2008;45:179-9.
60. Monea S, Jordan BA, Srivastava S, DeSouza S, Ziff EB. Membrane localization of membrane type 5 matrix metalloproteinase by AMPA receptor binding protein and cleavage of cadherins. J. Neurosci. 2006;26:2300-12.
61. Morales MM, Pires-Neto RC, Inforsato N, Lanças T, da Silva LF, Saldiva PH, Mauad T, Carvalho CR, Amato MB, Dolhnikoff M. Small airway remodeling in acute respiratory distress syndrome: a study in autopsy lung tissue. Crit. Care. 2011;15:R4.
62. Murphy SC; Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg. 2001;64:57-67.
63. Nagase H. Cell surface activation of progelatinase A (proMMP-2) and cell migration. Cell Res. 1998;8:179-86.
64. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J. Biol. Chem. 1999;274:21491-4.
65. Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res. 2006;69:562-73.
66. Nuti E, Tuccinardi T, Rossello A. Matrix metalloproteinase inhibitors: new challenges in the era of post broad-spectrum inhibitors. Curr. Pharm. Des. 2007;13:2087-100.
67. Nyangoto, EO. Cell-mediated effector molecules and complicated malaria. Int. Arch. Allergy Immunol. 2005;137:326-42.
68. Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop. 2003;87:193-205.
69. Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol. Biotechnol. 2002;22:51-86.
70. Overall CM, Dean RA. Degradomics: systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev. 2006;25:69-75.
71. Pinheiro BV, Muraoka FS, Assis RV, Lamin R, Pinto SP, Ribeiro PJ Jr, Oliveira JC. Accuracy of clinical diagnosis of acute respiratory distress syndrome in comparison with autopsy findings. J. Bras Pneumol. 2007;33:423-8.
72. Pongponratn E, Riganti M, Punpoowong B, Aikawa M. Microvascular sequestration of parasitized erythrocytes in human falciparum malaria: a pathological study. Am. J. Trop. Med. Hyg. 1991;44:168-75.
73. Prato M, Giribaldi G, Polimeni M, Gallo V, Arese P. Phagocytosis of hemozoin enhances matrix metalloproteinase-9 activity and TNF-alpha production in human monocytes: role of matrix metalloproteinases in the pathogenesis of falciparum malaria. J. Immunol. 2005;175:6436-42.
74. Prato M, Gallo V, Giribaldi G, Arese P. Phagocytosis of haemozoin (malarial pigment) enhances metalloproteinase-9 activity in human adherent monocytes: role of IL-1beta and 15-HETE. Malar. J. 2008;7:157.
75. Prato M, Giribaldi G, Arese P. Hemozoin triggers tumor necrosis factor alpha-mediated release of lysozyme by human adherent monocytes: new evidences on leukocyte degranulation in P. falciparum malaria. Asian Pac. J. Trop. Med. 2009;2(3):35-40.
76. Prato M, Gallo V, Giribaldi G, Aldieri E, Arese P. Role of the NF-κB transcription pathway in the haemozoin-and 15-HETE-mediated activation of matrix metalloproteinase-9 in human adherent monocytes. Cell Microbiol. 2010a;12:1780-91.
77. Prato M, Gallo V, Arese P. Higher production of tumor necrosis factor alpha in hemozoin-fed human adherent monocytes is dependent on lipidic component of malarial pigment: new evidences on cytokine regulation in P. falciparum malaria. Asian Pac. J. Trop. Med. 2010b;3:85-89.
78. Prato M, Giribaldi G. Matrix metalloproteinase-9 and haemozoin: wedding rings for human host and Plasmodium falciparum parasite in complicated malaria. J. Trop. Med. 2011a; 2011:ID ID628435.
79. Prato M, Valente E, Ulliers D, Khadjavi A, Giribaldi G. Quercetin, artemisinin and parthenolide abrogate the haemozoin-and 15-HETE-enhanced activity of enzymes released from gelatinase granules by human monocytes. Proceedings of the Antimal Conference-Antimalarial Drugs: Chemistry, Development and Future Challenges, London, UK, 15-16 March 2011. 2011b; P27:49.
80. Prato M, D'Alessandro S, Van den Steen PE, Opdenakker G, Arese P, Taramelli D, Basilico N. Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium. Cell Microbiol. 2011c; 13:1275-85.
81. Preece G, Murphy G, Ager A. Metalloproteinase-mediated regulation of L-selectin levels on leucocytes. J. Biol. Chem. 1996;271:11634.
82. Rasheed SA, Efferth T, Asangani IA, Allgayer H. First evidence that the antimalarial drug artesunate inhibits invasion and in vivo metastasis in lung cancer by targeting essential extracellular proteases. Int. J. Cancer. 2010;127:1475-85.
83. Ratnikov BI, Rozanov DV, Postnova TI, Baciu PG, Zhang H, DiScipio RG, Chestukhina GG, Smith JW, Deryugina EI, Strongin AY. An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 2002;277:7377-85.
84. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia. 2002;39:279-91.
85. Rosenberg GA, Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus. 2007;22:E4.
86. Santos-Martínez MJ, Medina C, Jurasz P, Radomski MW. Role of metalloproteinases in platelet function. Thromb Res. 2008;121:535-42.
87. Schönbeck U, Mach F, Libby P. Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol. 1998;161:3340-6.
88. Schrimpe AC, Wright DW. Comparative analysis of gene expression changes mediated by individual constituents of hemozoin. Chem. Res. Toxicol. 2009a;22:433-45.
89. Schrimpe AC, Wright DW. Differential gene expression mediated by 15hydroxyeicosatetraenoic acid in LPS-stimulated RAW 264.7 cells. Malar. J. 2009b;8:195.
90. Schwarzer E, Ludwig P, Valente E, Arese P. 15(S)-hydroxyeicosatetraenoic acid (15-HETE), a product of arachidonic acid peroxidation, is an active component of hemozoin toxicity to monocytes. Parassitologia. 1999;41:199-202.
91. Sherman IW, Eda S, Winograd E. Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect. 2003;5:897-909.
92. Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 2001;61:237-42.
93. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol. 2003;4:216.
94. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O. Cleavage and shedding of E-cadherin after induction of apoptosis. J. Biol. Chem. 2001;276:4972-80.
95. Stetler-Stevenson WG. Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci. Signal. 2008;1:re6.
96. Suguitan AL Jr, Leke RG, Fouda G, Zhou A, Thuita L, Metenou S, Fogako J, Megnekou R, Taylor DW. Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J. Infect. Dis. 2003;188:1074-82.
97. Szklarczyk A, Stins M, Milward EA, Ryu H, Fitzsimmons C, Sullivan D, Conant K. Glial activation and matrix metalloproteinase release in cerebral malaria. J. Neurovirol. 2007;13:2-10.
98. Tallant C, Marrero A, Gomis-Rüth FX. Matrix metalloproteinases: fold and function of their catalytic domains. Biochim. Biophys. Acta. 2010;1803:20-8.
99. Tripathi AK, Sullivan DJ, Stins MF. Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J. Infect. Dis. 2007;195:942-50.
100. Tripathi AK, Sha W, Shulaev V, Stins MF, Sullivan DJ Jr. Plasmodium falciparum-infected erythrocytes induce NF-kappaB regulated inflammatory pathways in human cerebral endothelium. Blood. 2009;114:4243-52.
101. Van den Steen PE, Proost P, Wuyts A, Van Damme J, Opdenakker G. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood. 2000;96:2673-81.
102. Van den Steen PE, Opdenakker G, Wormald MR, Dwek RA, Rudd PM. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim. Biophys. Acta. 2001;1528:61-73.
103. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit. Rev. Biochem. Mol. Biol. 2002;37:375-536.
104. Van Den Steen PE, Wuyts A, Husson SJ, Proost P, Van Damme J, Opdenakker G; Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur. J. Biochem. 2003a;270:3739-49.
105. Van den Steen PE, Husson SJ, Proost P, Van Damme J, Opdenakker G. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem. Biophys. Res. Commun. 2003b;310:889-96.
106. Van den Steen PE, Van Aelst I, Starckx S, Maskos K, Opdenakker G, Pagenstecher A. Matrix metalloproteinases, tissue inhibitors of MMPs and TACE in experimental cerebral malaria. Lab. Invest. 2006;86:873-88.
107. van der Heyde HC, Nolan J, Combes V, Gramaglia I, Grau GE. A unified hypothesis for the genesis of cerebral malaria: sequestration, inflammation and hemostasis leading to microcirculatory dysfunction. Trends Parasitol. 2006;22:503-8.
108. Van Wart HE, Birkedal-Hansen H. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U S A. 1990;87:5578-82.
109. von Bredow DC, Nagle RB, BowdenGT, Cress AE. Cleavage of beta 4 integrin by matrilysin. Exp. Cell Res. 1997;236:341-5.
110. Wang SJ, Sun B, Cheng ZX, Zhou HX, Gao Y, Kong R, Chen H, Jiang HC, Pan SH, Xue DB, Bai XW. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF-κB pathway. Cancer Chemother Pharmacol. 2011 Apr 9. (Epub ahead of print).
111. Wartenberg M, Wolf S, Budde P, Grünheck F, Acker H, Hescheler J, Wartenberg G, Sauer H. The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. Lab. Invest. 2003;83:1647-55.
112. Woessner JF Jr. MMPs and TIMPs--an historical perspective. Mol. Biotechnol. 2002;22:33-49.
113. Yu Q, Stamenkovic I. Cell surface-localizedmatrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14:163-76.